| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/25/2000 | US6017957 Partial agonists of the strychnine insensitive glycine modulatory site of the N-methyl-D-aspartate receptor complex as neuropsychopharmacological agents |
| 01/25/2000 | US6017946 Serotonin containing formulation for oral administration and method of use |
| 01/25/2000 | US6017929 Cholinesterase activator |
| 01/25/2000 | US6017915 Heterocyclic compounds |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017768 For screening agonists or antagonists of alpha adrenergic receptors, dopamine receptors, sigma opiate receptors, potassium ion channels, carbonic anhydrase inhibitors; for treatment of glaucoma |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017714 Netrins |
| 01/25/2000 | US6017541 Methyl ecgonine phenylphosphonates as analogues of transition states for the hydrolysis of the benzoyl ester of an ecgonine derivative, namely cocaine, and their linking to carrier proteins for use as immunogens |
| 01/25/2000 | CA2117466C Application of 2-amino 6-trifluoromethoxy benzothiazole for obtaining a drug useful in the treatment of motor neuron diseases |
| 01/25/2000 | CA2086433C Indano pyrrolidine carbamates |
| 01/25/2000 | CA2073055C Nicotine containing stimulant unit |
| 01/20/2000 | WO2000003248A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | WO2000003004A2 Presenilin 2 specific ribozyme |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002904A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
| 01/20/2000 | WO2000002877A2 New pharmaceutically active compounds |
| 01/20/2000 | WO2000002870A1 Antiviral macrocyclic compounds |
| 01/20/2000 | WO2000002865A1 Pharmaceutical agents |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002859A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | WO2000002858A1 Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002839A1 Cytokine production and tyrosine kinase inhibitors |
| 01/20/2000 | WO2000002592A1 Pharmaceutical composition containinig gaba analogs and an antiviral agent to treat shingles |
| 01/20/2000 | WO2000002562A1 Compositions comprising gaba analogs and caffeine |
| 01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | WO2000002547A2 The treatment of renal colic with gaba analogs |
| 01/20/2000 | WO2000002546A2 Use of caba-analogues for treating insomnia |
| 01/20/2000 | WO2000002545A2 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | WO2000002543A2 Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/20/2000 | WO2000002542A2 Agents with an antidepressive effect containing pramipexol and an additional antidepressant drug |
| 01/20/2000 | WO2000002519A2 Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain |
| 01/20/2000 | WO2000002455A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 01/20/2000 | WO1999055672A3 Antipsychotic indolyl derivatives |
| 01/20/2000 | WO1999053943A3 Therapeutic angiogenic factors and methods for their use |
| 01/20/2000 | WO1999048858A3 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/20/2000 | WO1999021542A3 Methods for modulating macrophage proliferation using polyamine analogs |
| 01/20/2000 | CA2337795A1 Pharmaceutical agents |
| 01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2336806A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | CA2336784A1 Use of tetrahydropyridine or (4-hydroxypiperidine)-butylazoles in the preparation of a medicament for the treatment of pain |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2332927A1 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332497A1 Presenilin 2 specific ribozyme |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972773A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates |
| 01/19/2000 | EP0972515A2 Cyclooxygenase Inhibitor |
| 01/19/2000 | EP0972053A1 Novel human serine carboxypeptidase |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0971959A1 Humanized antibodies and methods for forming humanized antibodies |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971930A1 Process for preparing single enantiomer narwedine |
| 01/19/2000 | EP0971929A1 2,3-DIHYDROFURO 3,2-$i(b)]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/19/2000 | EP0971897A1 Anti-convulsant isoquinolyl-benzamide derivatives |
| 01/19/2000 | EP0971896A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971887A1 Metalloproteinase inhibitors |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0971714A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
| 01/19/2000 | EP0971713A1 Use of cholinesterase inhibitors to treat disorders of attention |
| 01/19/2000 | EP0971709A1 Novel compounds useful as neuro-protective agents |
| 01/19/2000 | EP0971695A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 01/19/2000 | EP0971601A1 Decaffeinated mate extracts and the use thereof |
| 01/19/2000 | EP0841950A4 Neuronal progenitor cells and uses thereof |
| 01/19/2000 | EP0746322B1 Treatment of alzheimer's disease with delta5-androstenes |
| 01/19/2000 | EP0728144B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
| 01/19/2000 | EP0723546B1 1,2,4 - TRIZOLO[1,5-a]PYRIMIDINE AND THEIR USE FOR TREATMENT OF NEUROLOGICAL DISORDERS |
| 01/19/2000 | CN1242007A Cycloalkyl, lactam lactone and related compounds as 'beta'-amyloid peptide release inhibitors |
| 01/19/2000 | CN1242006A Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1242001A Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1048492C Quinuclidine derivatives and its preparation |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015900 N-aminoalkylfluorenecarboxamides |
| 01/18/2000 | US6015879 Compounds for treatment of nervous system disorders including alzheimer's disease, cognition defects, down's syndrome, parkinson's disease, cerebral hemorrhage with amyloidosis, dementia pugilistica, and head trauma |
| 01/18/2000 | US6015835 Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| 01/18/2000 | US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders |
| 01/18/2000 | US6015831 Thiophene nitrone compounds |
| 01/18/2000 | US6015824 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders |
| 01/18/2000 | US6015786 Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |